Choueiri, T. K., Xie, W., D’Amico, A. V., Ross, R. W., Hu, J. C., Pomerantz, M., . . . Oh, W. K. (2009). Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy.
Chicago Stili AlıntıChoueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
MLA AlıntıChoueiri, Toni K., et al. Time to PSA Nadir Independently Predicts Overall Survival in Metastatic Hormone Sensitive Prostate Cancer Patients Treated With Androgen Deprivation Therapy. 2009.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..